Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Patients / recruits are not guaranteed. Last trial this was a...

First 27 Last

Share
Profile

Follow
arkus

939 Posts.

239

23/07/24

20:11

Post #: 74881022
Share

Originally posted by Shellbell: ↑

Well, according to the ann, the CDH17 trials are being fast-tracked in the sense that they are staged. Stage 1 is dose escalation and Stage 2 expanded recruitment at the optimal dose for each of three different trials (or cancer types). That is smart trial design. Instead of a doing a single basket trial and hoping for one-size dose fits all approach, its honing in on getting maximum clinical activity in what is traditionally just a safety trial. In a way, it truncates the process and potentially ensures the next (possible) trials for CDH17 will be registrational trials.

This shows what the CHM management are considering as an achievable timeline for each of our programs within the year:-

So, we have lots of clinical milestones, data and pre-clinical newsflow to come.... and we are already into the 7th of the year. The funding issue is likely to be an interesting one given the pipeline and the newsflow for the rest of 2024.

Expand

Patients / recruits are not guaranteed. Last trial this was a problem right, along with the specialists req to administer.

CHM Price at posting: 2.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

FFM

Firefly positioned for copper growth in Canada ahead of resource update

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 10 more messages in this thread...

First 27 Last

Add CHM (ASX) to my watchlist